"Thirty-one MPs have signed a House of Commons motion voicing their disapproval of the health secretary being handed the power to override NICE's judgment on NHS spending for medicines."
"McDonnell stated that one of the express purposes of establishing NICE was to insulate the NHS from the powerful lobbying of the pharmaceutical industry, which the current changes threaten."
"The changes the government are making to NICE as a result of the US pharmaceutical deal undermine its independence, giving US big pharma the potential for immense influence over drug policies."
Thirty-one MPs have expressed opposition to Wes Streeting's authority to dictate NHS drug pricing, fearing it undermines the National Institute for Health and Care Excellence's (NICE) role. Concerns center on the potential for a power grab that could allow pharmaceutical companies to influence drug pricing. The change is seen as a threat to NHS resources and patient care. A statutory instrument has granted Streeting the ability to direct NICE on cost-effectiveness thresholds, raising alarms about the impact of US pharmaceutical lobbying on NHS policies.
Read at www.theguardian.com
Unable to calculate read time
Collection
[
|
...
]